The MSDD degree program offers individuals already working in the industry with an opportunity to acquire advanced training in research activity as conducted and required by the US Food and Drug Administration (US FDA) and by other regulatory agencies.
Career opportunities in this field are substantial. According to EvaluatePharma’s World Preview 2019, Outlook to 2024, prescription drug sales are expected to reach $1.18 trillion by 2024. The report notes that immuno-oncology line extensions significantly contribute to growth as well as the emergence of novel technologies such as cell and gene therapy mark an inflection point in pharma’s evolution.
In the US, the Bureau of Labor Statistics (BLS) predicts that the medical scientists’ workforce will grow by 8% from 2018 to 2028 – faster than the average for all occupations in the US. Further, medical scientists will continue to be needed as they contribute to the development of treatments and medicines that improve human health.
For clinical laboratory technologists and technicians, the BLS notes that employment is projected to grow 11% from 2018 to 2028. An increase in the aging population is expected to lead to a greater need to diagnose medical conditions, such as cancer or type 2 diabetes, through laboratory procedures.
Further, BLS states that jobs for biochemists and biophysicists are projected to grow 6% from 2018 to 2028 with more individuals needed in this field to use the knowledge they have gained from basic research to develop biological products and processes that improve lives.
Given the scope and breadth of knowledge covered by this program, the acquired learning and skills will equip students to advance their career in research and drug development.
Possible careers depending on prior education, areas of expertise, and experience include:
“MSDD program has been a turning point in my professional career, which pivots around the CRO industry. The MSDD program exposed me to the myriad facets intertwined in the complex, and highly regulated field of clinical research and drug developments. Courses are structured to cover all major topics and functions covering the drug development and are taught by a thoughtful hand-picked mix of industry leaders, working professionals, and competent academicians. This allows for real-world insights into the drug development field.”
The MS in Drug Development program is typically completed in 5 semesters or 1 and 2/3 years if taken part-time.
For the MS Pharm Sci: Drug Development program, A grade-point average (GPA) of at least 3.00 or foreign equivalent is recommended.
Please visit the Admissions Requirements page for more information.
The University of Cincinnati is one of the first institutions to offer online courses. Innovation in education is at the forefront of what we do. We have expanded the convenience and quality of our online learning to online degree programs. Today, we offer nearly 100 degrees from undergraduate to doctoral programs.
Connect with an Advisor
© 2021 University of Cincinnati Online Copyright Information